{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:16:41Z","timestamp":1789827401707,"version":"4.0.1"},"reference-count":131,"publisher":"Institute of Physiology of the Czech Academy of Sciences","issue":"Suppl. 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>The sex steroid hormones (SSHs) such as testosterone, estradiol, progesterone, and their metabolites have important organizational and activational impacts on the brain during critical periods of brain development and in adulthood. A variety of slow and rapid mechanisms mediate both organizational and activational processes via intracellular or membrane receptors for SSHs. Physiological concentrations and distribution of SSHs in the brain result in normal brain development. Nevertheless, dysregulation of hormonal equilibrium may result in several mood disorders, including depressive disorders, later in adolescence or adulthood. Gender differences in cognitive abilities, emotions as well as the 2-3 times higher prevalence of depressive disorders in females, were already described. This implies that SSHs may play a role in the development of depressive disorders. In this review, we discuss preclinical and clinical studies linked to SSHs and development of depressive disorders. Our secondary aim includes a review of up-to-date knowledge about molecular mechanisms in the pathogenesis of depressive disorders. Understanding these molecular mechanisms might lead to significant treatment adjustments for patients with depressive disorders and to an amelioration of clinical outcomes for these patients. Nevertheless, the impact of SSHs on the brain in the context of the development of depressive disorders, progression, and treatment responsiveness is complex in nature, and depends upon several factors in concert such as gender, age, comorbidities, and general health conditions.<\/jats:p>","DOI":"10.33549\/physiolres.935001","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T15:22:23Z","timestamp":1674487343000},"page":"S187-S202","source":"Crossref","is-referenced-by-count":19,"title":["Sex Steroid Hormones in Depressive Disorders as a Basis for New Potential Treatment Strategies"],"prefix":"10.33549","volume":"71","author":[{"given":"M","family":"PILLEROV\u00c1","sequence":"first","affiliation":[{"name":"Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"PASTOREK","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"BORB\u00c9LYOV\u00c1","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"RILJAK","sequence":"additional","affiliation":[{"name":"Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"FRICK","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"HODOSY","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"T\u00d3THOV\u00c1","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.\tAmerican Psychiatric Association: Mood disorder. In: Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed Washington, DC, 2013. https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.\tEllenbroek B, Youn J: Affective Disorders. In: Gene-Environment Interactions in Psychiatry: Nature, Nurture, Neuroscience. Academic Press, 2016, pp 173-231. https:\/\/doi.org\/10.1016\/B978-0-12-801657-2.00007-0","DOI":"10.1016\/b978-0-12-801657-2.00007-0"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tTemin P: Great Depression. In: Banking Crises. JONES G (ed.), Palgrave Macmillan, London, 2016, pp 144-153. https:\/\/doi.org\/10.1057\/9781137553799_16","DOI":"10.1057\/9781137553799_16"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tLeMoult J, Gotlib IH. Depression: A cognitive perspective. Clin Psychol Rev 2019;69:51-66. https:\/\/doi.org\/10.1016\/j.cpr.2018.06.008","DOI":"10.1016\/j.cpr.2018.06.008"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.\tLim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep 2018;1:2861. https:\/\/doi.org\/10.1038\/s41598-018-21243-x","DOI":"10.1038\/s41598-018-21243-x"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tMurrell SA, Himmelfarb S, Wright K. Prevalence of depression and its correlates in older adults. Am J Epidemiol 1983;2:173-185. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a113528","DOI":"10.1093\/oxfordjournals.aje.a113528"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.\tGater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care. Arch Gen Psychiatry 1998;5:405-413. https:\/\/doi.org\/10.1001\/archpsyc.55.5.405","DOI":"10.1001\/archpsyc.55.5.405"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.\tCharlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet 2019;10194:240-248. https:\/\/doi.org\/10.1016\/S0140-6736(19)30934-1","DOI":"10.1016\/s0140-6736(19)30934-1"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.\tAlbert PR. Why is depression more prevalent in women? J Psychiatry Neurosci 2015;4:219-221. https:\/\/doi.org\/10.1503\/jpn.150205","DOI":"10.1503\/jpn.150205"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.\tWilliams CL. A reevaluation of the concept of separable periods of organizational and activational actions of estrogens in development of brain and behavior. Ann N Y Acad Sci 1986;282-292. https:\/\/doi.org\/10.1111\/j.1749-6632.1986.tb28019.x","DOI":"10.1111\/j.1749-6632.1986.tb28019.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.\tCooke B, Hegstrom CD, Villeneuve LS, Breedlove SM. Sexual differentiation of the vertebrate brain: principles and mechanisms. Front Neuroendocrinol 1998;4:323-362. https:\/\/doi.org\/10.1006\/frne.1998.0171","DOI":"10.1006\/frne.1998.0171"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.\tSchulz KM, Sisk CL. The organizing actions of adolescent gonadal steroid hormones on brain and behavioral development. Neurosci Biobehav Rev 2016;70:148-158. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.07.036","DOI":"10.1016\/j.neubiorev.2016.07.036"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.\tVigil P, Del R\u00edo JP, Carrera B, Ar\u00c1nguiz FC, Rioseco H, Cort\u00e9s ME. Influence of sex steroid hormones on the adolescent brain and behavior: An update. Linacre Q 2016;3:308-329. https:\/\/doi.org\/10.1080\/00243639.2016.1211863","DOI":"10.1080\/00243639.2016.1211863"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.\tBlankers SA, Galea LAM. Androgens and adult neurogenesis in the hippocampus. Androg Clin Res Ther 2021;1:203-215. https:\/\/doi.org\/10.1089\/andro.2021.0016","DOI":"10.1089\/andro.2021.0016"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.\tPivina SG, Akulova VK, Ordyan NE. Characteristics of behavior and stress reactivity of the hypophyseal-adrenocortical system in rats with prenatal inhibition of testosterone metabolism. Neurosci Behav Physiol 2007;1:53-58. https:\/\/doi.org\/10.1007\/s11055-007-0149-6","DOI":"10.1007\/s11055-007-0149-6"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.\tFilov\u00e1 B, Ostatn\u00edkov\u00e1 D, Celec P, Hodosy J. The effect of testosterone on the formation of brain structures. Cells Tissues Organs 2013;3:169-177. https:\/\/doi.org\/10.1159\/000345567","DOI":"10.1159\/000345567"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.\tKajta M, Wnuk A, Rzemieniec J, Litwa E, Lason W, Zelek-Molik A, Nalepa I, Rog\u00f3\u017c Z, Grochowalski A, Wojtowicz AK. Depressive-like effect of prenatal exposure to DDT involves global DNA hypomethylation and impairment of GPER1\/ESR1 protein levels but not ESR2 and AHR\/ARNT signaling. J Steroid Biochem Mol Biol 2017;171:94-109. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.03.001","DOI":"10.1016\/j.jsbmb.2017.03.001"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.\tLi W, Luo L-Y, Yang X, He Y, Lian B, Qu C-H, Wu Q-Y, Zhang J-G, Xie P. Depressed female cynomolgus monkeys (Macaca fascicularis) display a higher second-to-fourth (2D:4D) digit ratio. Zool Res 2019;3:219-225. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2019.022","DOI":"10.24272\/j.issn.2095-8137.2019.022"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.\tKessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;1:8-19. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950010008002","DOI":"10.1001\/archpsyc.1994.03950010008002"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.\tMendell AL, MacLusky NJ. Neurosteroid metabolites of gonadal steroid hormones in neuroprotection: implications for sex differences in neurodegenerative disease. Front Mol Neurosci 2018;11:359. https:\/\/doi.org\/10.3389\/fnmol.2018.00359","DOI":"10.3389\/fnmol.2018.00359"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.\tSolomon MB, Herman JP. Sex differences in psychopathology: of gonads, adrenals and mental illness. Physiol Behav 2009;2:250-258. https:\/\/doi.org\/10.1016\/j.physbeh.2009.02.033","DOI":"10.1016\/j.physbeh.2009.02.033"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.\tNolen-Hoeksema S, Larson J, Grayson C. Explaining the gender difference in depressive symptoms. J Pers Soc Psychol 1999;5:1061-1072. https:\/\/doi.org\/10.1037\/0022-3514.77.5.1061","DOI":"10.1037\/0022-3514.77.5.1061"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.\tMontgomery JC, Brincat M, Tapp A, Appleby L, Versi E, Fenwick PBC, Studd JWW. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;8528:297-299. https:\/\/doi.org\/10.1016\/S0140-6736(87)92026-5","DOI":"10.1016\/s0140-6736(87)92026-5"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.\tFink G, Sumner B, Rosie R, Wilson H, McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 1999;1:53-68. https:\/\/doi.org\/10.1016\/S0166-4328(99)00082-0","DOI":"10.1016\/s0166-4328(99)00082-0"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.\tGalea LAM, Wide JK, Barr AM. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res 2001;1:1-9. https:\/\/doi.org\/10.1016\/S0166-4328(01)00170-X","DOI":"10.1016\/s0166-4328(01)00170-x"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26.\tFrye C, Walf A, Rhodes M, Harney J. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5alpha-reductase. Brain Res 2004;1004:116-124. https:\/\/doi.org\/10.1016\/j.brainres.2004.01.020","DOI":"10.1016\/j.brainres.2004.01.020"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.\tWalf AA, Frye CA. Estradiol reduces anxiety- and depression-like behavior of aged female mice. Physiol Behav 2010;2:169-174. https:\/\/doi.org\/10.1016\/j.physbeh.2009.09.017","DOI":"10.1016\/j.physbeh.2009.09.017"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.\tMiller KK, Wexler TL, Zha AM, Lawson EA, Meenaghan EM, Misra M, Binstock AB, Herzog DB, Klibanski A. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psych 2007;6:959-965. https:\/\/doi.org\/10.4088\/JCP.v68n0621","DOI":"10.4088\/jcp.v68n0621"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.\tChaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med 2018;3:239-246. https:\/\/doi.org\/10.4103\/IJPSYM.IJPSYM_561_17","DOI":"10.4103\/ijpsym.ijpsym_561_17"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.\tGordon JL, Peltier A, Grummisch JA, Sykes Tottenham L. Estradiol fluctuation, sensitivity to stress, and depressive symptoms in the menopause transition: a pilot study. Front Psychol 2019;10:1319. https:\/\/doi.org\/10.3389\/fpsyg.2019.01319","DOI":"10.3389\/fpsyg.2019.01319"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.\tGoldstein JM, Seidman LJ, Horton NJ, Makris N, Kennedy DN, Caviness VS, Jr., Faraone SV, Tsuang MT. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex 2001;6:490-497. https:\/\/doi.org\/10.1093\/cercor\/11.6.490","DOI":"10.1093\/cercor\/11.6.490"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.\tGoldman-Rakic PS, Cools AR, Srivastava K, Roberts AC, Robbins TW, Weiskrantz L. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos Trans R Soc Lond B Biol Sci 1996;1346:1445-1453. https:\/\/doi.org\/10.1098\/rstb.1996.0129","DOI":"10.1098\/rstb.1996.0129"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.\tTeffer K, Semendeferi K: Human prefrontal cortex: Evolution, development, and pathology. In: Progress in Brain Research. HOFMAN MA, FALK D (eds), Elsevier, 2012, pp 191-218. https:\/\/doi.org\/10.1016\/B978-0-444-53860-4.00009-X","DOI":"10.1016\/b978-0-444-53860-4.00009-x"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.\tMiller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001;1:167-202. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.167","DOI":"10.1146\/annurev.neuro.24.1.167"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.\tFunahashi S, Bruce CJ, Goldman-Rakic PS. Dorsolateral prefrontal lesions and oculomotor delayed-response performance: evidence for mnemonic\" scotomas\". J Neurosci 1993;4:1479-1497. https:\/\/doi.org\/10.1523\/JNEUROSCI.13-04-01479.1993","DOI":"10.1523\/jneurosci.13-04-01479.1993"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.\tGabrieli JDE, Poldrack RA, Desmond JE. The role of left prefrontal cortex in language and\u2009memory. Proc Natl Acad Sci U S A 1998;3:906. https:\/\/doi.org\/10.1073\/pnas.95.3.906","DOI":"10.1073\/pnas.95.3.906"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.\tGuadagno A, Belliveau C, Mechawar N, Walker C-D. Effects of early life stress on the developing basolateral amygdala-prefrontal cortex circuit: the emerging role of local inhibition and perineuronal nets. Front Hum Neurosci 2021;15:669120. https:\/\/doi.org\/10.3389\/fnhum.2021.669120","DOI":"10.3389\/fnhum.2021.669120"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.\tFeldman S, Conforti N, Weidenfeld J. Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci Biobehav Rev 1995;2:235-240. https:\/\/doi.org\/10.1016\/0149-7634(94)00062-6","DOI":"10.1016\/0149-7634(94)00062-6"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.\t\u00d6hman A. The role of the amygdala in human fear: Automatic detection of threat. Psychoneuroendocrinology 2005;10:953-958. https:\/\/doi.org\/10.1016\/j.psyneuen.2005.03.019","DOI":"10.1016\/j.psyneuen.2005.03.019"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40.\tBaxter MG, Croxson PL. Facing the role of the amygdala in emotional information processing. Proc Natl Acad Sci U S A 2012;52:21180. https:\/\/doi.org\/10.1073\/pnas.1219167110","DOI":"10.1073\/pnas.1219167110"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41.\tH\u00f6fer P, Lanzenberger R, Kasper S. Testosterone in the brain: Neuroimaging findings and the potential role for neuropsychopharmacology. Eur Neuropsychopharmacol 2013;2:79-88. https:\/\/doi.org\/10.1016\/j.euroneuro.2012.04.013","DOI":"10.1016\/j.euroneuro.2012.04.013"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. \tPapadimitriou A, Priftis KN. Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation 2009;5:265-271. https:\/\/doi.org\/10.1159\/000216184","DOI":"10.1159\/000216184"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43.\tSheline YI, Mittler BL, Mintun MA. The hippocampus and depression. Eur Psychiatry 2002;S3:300s-305s. https:\/\/doi.org\/10.1016\/S0924-9338(02)00655-7","DOI":"10.1016\/s0924-9338(02)00655-7"},{"key":"ref43","unstructured":"44.\tCampbell M, Jialal I. Physiology, Endocrine Hormones. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45.\tAnand KS, Dhikav V. Hippocampus in health and disease: An overview. Ann Ind Acad Neurol 2012;4:239-246. https:\/\/doi.org\/10.4103\/0972-2327.104323","DOI":"10.4103\/0972-2327.104323"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46.\tStevens JS, Hamann S. Sex differences in brain activation to emotional stimuli: A meta-analysis of neuroimaging studies. Neuropsychologia 2012;7:1578-1593. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2012.03.011","DOI":"10.1016\/j.neuropsychologia.2012.03.011"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47.\tVaridaki A, Mohammad H, Coffey ET: Molecular mechanisms of depression. In: Systems Neuroscience in Depression. FRODL T (ed.), Academic Press, 2016, pp 143-178. https:\/\/doi.org\/10.1016\/B978-0-12-802456-0.00005-4","DOI":"10.1016\/b978-0-12-802456-0.00005-4"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48.\tHare BD, Duman RS. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions. Mol Psychiatry 2020;11:2742-2758. https:\/\/doi.org\/10.1038\/s41380-020-0685-9","DOI":"10.1038\/s41380-020-0685-9"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49.\tGuerra-Araiza C, Coyoy-Salgado A, Camacho-Arroyo I. Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull 2002;2:105-109. https:\/\/doi.org\/10.1016\/S0361-9230(02)00845-6","DOI":"10.1016\/s0361-9230(02)00845-6"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50.\tFoster TC. Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus 2012;4:656-669. https:\/\/doi.org\/10.1002\/hipo.20935","DOI":"10.1002\/hipo.20935"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"51.\tBerg AH, Rice CD, Rahman MS, Dong J, Thomas P. Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: I. Discovery in female atlantic croaker and evidence ZIP9 mediates testosterone-induced apoptosis of ovarian follicle cells. Endocrinology 2014;11:4237-4249. https:\/\/doi.org\/10.1210\/en.2014-1198","DOI":"10.1210\/en.2014-1198"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52.\tAlmey A, Milner TA, Brake WG. Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females. Horm Behav 2015;125-138. https:\/\/doi.org\/10.1016\/j.yhbeh.2015.06.010","DOI":"10.1016\/j.yhbeh.2015.06.010"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53.\tP\u00e9rez SE, Chen EY, Mufson EJ. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Dev Brain Res 2003;1:117-139. https:\/\/doi.org\/10.1016\/S0165-3806(03)00223-2","DOI":"10.1016\/s0165-3806(03)00223-2"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54.\tGorelick DA, Watson W, Halpern ME. Androgen receptor gene expression in the developing and adult zebrafish brain. Dev Dyn 2008;10:2987-2995. https:\/\/doi.org\/10.1002\/dvdy.21700","DOI":"10.1002\/dvdy.21700"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55.\tBelovicova K, Bogi E, Csatlosova K, Dubovicky M. Animal tests for anxiety-like and depression-like behavior in rats. Interdiscip Toxicol 2017;1:40-43. https:\/\/doi.org\/10.1515\/intox-2017-0006","DOI":"10.1515\/intox-2017-0006"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56.\tCarrier N, Kabbaj M. Testosterone and imipramine have antidepressant effects in socially isolated male but not female rats. Horm Behav 2012;5:678-685. https:\/\/doi.org\/10.1016\/j.yhbeh.2012.03.001","DOI":"10.1016\/j.yhbeh.2012.03.001"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57.\tZhang JM, Tonelli L, Regenold WT, McCarthy MM. Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats. Neuroscience 2010;1:544-554. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.03.029","DOI":"10.1016\/j.neuroscience.2010.03.029"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58.\tManning J, Kilduff L, Cook C, Crewther B, Fink B. Digit ratio (2D: 4D): a biomarker for prenatal sex steroids and adult sex steroids in challenge situations. Front Endocrinol (Lausanne) 2014;5;9. https:\/\/doi.org\/10.3389\/fendo.2014.00009","DOI":"10.3389\/fendo.2014.00009"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"59.\tVentura T, Gomes MC, Pita A, Neto MT, Taylor A. Digit ratio (2D:4D) in newborns: Influences of prenatal testosterone and maternal environment. Early Hum Dev 2013;2:107-112. https:\/\/doi.org\/10.1016\/j.earlhumdev.2012.08.009","DOI":"10.1016\/j.earlhumdev.2012.08.009"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60.\tMcHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol 2014;1:42-57. https:\/\/doi.org\/10.1016\/j.yfrne.2013.09.001","DOI":"10.1016\/j.yfrne.2013.09.001"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"61.\tBlack SR, Goldstein BL, Klein DN. Parental depression moderates the relationships of cortisol and testosterone with children's symptoms. J Affect Disord 2019;251:42-51. https:\/\/doi.org\/10.1016\/j.jad.2019.01.047","DOI":"10.1016\/j.psyneuen.2018.12.151"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"62.\tSu Q-R, Su L-Y, Su H-R, Chen Q, Ren G-Y, Yin YOU, Shen S-Q, Yu A-Y, Xia G-Y. Polymorphisms of androgen receptor gene in childhood and adolescent males with first-onset major depressive disorder and association with related symptomatology. Int J Neurosci 2007;7:903-917. https:\/\/doi.org\/10.1080\/00207450600910689","DOI":"10.1080\/00207450600910689"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"63.\tSankar JS, Hampson E. Testosterone levels and androgen receptor gene polymorphism predict specific symptoms of depression in young men. Gend Med 2012;4:232-243. https:\/\/doi.org\/10.1016\/j.genm.2012.05.001","DOI":"10.1016\/j.genm.2012.05.001"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"64.\tChamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;15:3181-3186. https:\/\/doi.org\/10.1093\/nar\/22.15.3181","DOI":"10.1093\/nar\/22.15.3181"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"65.\tTut TG, Ghadessy FJ, Trifiro M, Pinsky L, Yong E. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 1997;11:3777-3782. https:\/\/doi.org\/10.1210\/jc.82.11.3777","DOI":"10.1210\/jcem.82.11.4385"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"66.\tM\u00f6hlig M, Arafat AM, Osterhoff MA, Isken F, Weickert MO, Spranger J, Pfeiffer AF, Sch\u00f6fl C. Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men. Europ J Endocrinol 2011;6:1013. https:\/\/doi.org\/10.1530\/EJE-10-1022","DOI":"10.1530\/eje-10-1022"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"67.\tTsai S-J, Wang Y-C, Hong C-J, Chiu H-J. Association study of oestrogen receptor \u03b1 gene polymorphism and suicidal behaviours in major depressive disorder. Psychiatr Genet 2003;1:19-22. https:\/\/doi.org\/10.1097\/00041444-200303000-00003","DOI":"10.1097\/00041444-200303000-00003"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"68.\tKravitz HM, Janssen I, Lotrich FE, Kado DM, Bromberger JT. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife. Am J Med 2006;119(9 Suppl 1):S87-S93. https:\/\/doi.org\/10.1016\/j.amjmed.2006.07.010","DOI":"10.1016\/j.amjmed.2006.07.010"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"69.\tSeidman SN, Araujo AB, Roose SP, McKinlay JB. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 2001;5:371-376. https:\/\/doi.org\/10.1016\/S0006-3223(01)01148-9","DOI":"10.1016\/s0006-3223(01)01148-9"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"70.\tChhibber A, Woody SK, Karim Rumi MA, Soares MJ, Zhao L. Estrogen receptor \u03b2 deficiency impairs BDNF-5-HT(2A) signaling in the hippocampus of female brain: A possible mechanism for menopausal depression. Psychoneuroendocrinology 2017;82:107-116. https:\/\/doi.org\/10.1016\/j.psyneuen.2017.05.016","DOI":"10.1016\/j.psyneuen.2017.05.016"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"71.\tSch\u00fcle C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 2011;191:55-77. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.03.025","DOI":"10.1016\/j.neuroscience.2011.03.025"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"72.\tWang J, Li H-Y, Shen S-Y, Zhang J-R, Liang L-F, Huang H-J, Li B, Wu G-C, Zhang Y-Q, Yu J. The antidepressant and anxiolytic effect of GPER on translocator protein (TSPO) via protein kinase a (PKA) signaling in menopausal female rats. J Steroid Biochem Mol Biol 2021;207:105807. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105807","DOI":"10.1016\/j.jsbmb.2020.105807"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"73.\tFindikli E, Kurutas EB, Camkurt MA, Karaaslan MF, Izci F, F\u0131nd\u0131kl\u0131 HA, Karda\u015f S, Dag B, Altun H. Increased serum G protein-coupled estrogen receptor 1 levels and its diagnostic value in drug na\u00efve patients with major depressive disorder. Clin Psychopharmacol Neurosci 2017;4:337-342. https:\/\/doi.org\/10.9758\/cpn.2017.15.4.337","DOI":"10.9758\/cpn.2017.15.4.337"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"74.\tHung Y-Y, Huang Y-L, Chang C, Kang H-Y. Deficiency in androgen receptor aggravates the depressive-like behaviors in chronic mild stress model of depression. Cells 2019;9:1021. https:\/\/doi.org\/10.3390\/cells8091021","DOI":"10.3390\/cells8091021"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"75.\tFuruta M, Numakawa T, Chiba S, Ninomiya M, Kajiyama Y, Adachi N, Akema T, Kunugi H. Estrogen, predominantly via estrogen receptor \u03b1, attenuates postpartum-induced anxiety- and depression-like behaviors in female rats. Endocrinology 2013;10:3807-3816. https:\/\/doi.org\/10.1210\/en.2012-2136","DOI":"10.1210\/en.2012-2136"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"76.\tRocha BA, Fleischer R, Schaeffer JM, Rohrer SP, Hickey GJ. 17\u03b2-Estradiol-induced antidepressant-like effect in the Forced Swim Test is absent in estrogen receptor-\u03b2 knockout (BERKO) mice. Psychopharmacology 2005;3:637-643. https:\/\/doi.org\/10.1007\/s00213-004-2078-1","DOI":"10.1007\/s00213-004-2078-1"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"77.\tBastos CP, Pereira LM, Ferreira-Vieira TH, Drumond LE, Massensini AR, Moraes MF, Pereira GS. Object recognition memory deficit and depressive-like behavior caused by chronic ovariectomy can be transitorialy recovered by the acute activation of hippocampal estrogen receptors. Psychoneuroendocrinology 2015;57:14-25. https:\/\/doi.org\/10.1016\/j.psyneuen.2015.03.020","DOI":"10.1016\/j.psyneuen.2015.03.020"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"78.\tWalf AA, Frye CA. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav 2007;2:407-414. https:\/\/doi.org\/10.1016\/j.pbb.2006.07.003","DOI":"10.1016\/j.pbb.2006.07.003"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79.\tWalf AA, Frye CA. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 2006;6:1097-1111. https:\/\/doi.org\/10.1038\/sj.npp.1301067","DOI":"10.1038\/sj.npp.1301067"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"80.\tXu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X. NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun 2016;175-186. https:\/\/doi.org\/10.1016\/j.bbi.2016.02.022","DOI":"10.1016\/j.bbi.2016.02.022"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"81.\tWang J, Yu R, Han Q-Q, Huang H-J, Wang Y-L, Li H-Y, Wang H-M, Chen X-R, Ma S-L, Yu J. G-1 exhibit antidepressant effect, increase of hippocampal ERs expression and improve hippocampal redox status in aged female rats. Behav Brain Res 2019;359:845-852. https:\/\/doi.org\/10.1016\/j.bbr.2018.07.017","DOI":"10.1016\/j.bbr.2018.07.017"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"82.\tBopassa JC, Eghbali M, Toro L, Stefani E. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2010;1:H16-H23. https:\/\/doi.org\/10.1152\/ajpheart.00588.2009","DOI":"10.1152\/ajpheart.00588.2009"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"83.\tJia C, Brown RW, Malone HM, Burgess KC, Gill WD, Keasey MP, Hagg T. Ciliary neurotrophic factor is a key sex-specific regulator of depressive-like behavior in mice. Psychoneuroendocrinology 2019;100:96-105. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.09.038","DOI":"10.1016\/j.psyneuen.2018.09.038"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"84.\tHellgren C, \u00c5kerud H, Skalkidou A, B\u00e4ckstr\u00f6m T, Sundstr\u00f6m-Poromaa I. Low serum allopregnanolone is associated with symptoms of depression in late pregnancy. Neuropsychobiology 2014;3:147-153. https:\/\/doi.org\/10.1159\/000358838","DOI":"10.1159\/000358838"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"85.\tAlmeida FB, Nin MS, Barros HMT. The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins. Neurobiol Stres 2020;12:100218. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100218","DOI":"10.1016\/j.ynstr.2020.100218"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"86.\tSch\u00fcle C, Nothdurfter C, Rupprecht R. The role of allopregnanolone in depression and anxiety. Prog Neurobiol 2014;79-87. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.09.003","DOI":"10.1016\/j.pneurobio.2013.09.003"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"87.\tFrye CA, Walf AA. Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav 2002;3:306-315. https:\/\/doi.org\/10.1006\/hbeh.2002.1763","DOI":"10.1006\/hbeh.2002.1763"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"88.\tShirayama Y, Fujita Y, Oda Y, Iwata M, Muneoka K, Hashimoto K. Allopregnanolone induces antidepressant-like effects through BDNF-TrkB signaling independent from AMPA receptor activation in a rat learned helplessness model of depression. Behav Brain Res 2020;390:112670. https:\/\/doi.org\/10.1016\/j.bbr.2020.112670","DOI":"10.1016\/j.bbr.2020.112670"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"89.\tChen S, Gao L, Li X, Ye Y. Allopregnanolone in mood disorders: Mechanism and therapeutic development. Pharmacol Res 2021;169:105682. https:\/\/doi.org\/10.1016\/j.phrs.2021.105682","DOI":"10.1016\/j.phrs.2021.105682"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"90.\tBao A-M, Swaab DF. The human hypothalamus in mood disorders: the HPA axis in the center. IBRO Rep 2019;6:45-53. https:\/\/doi.org\/10.1016\/j.ibror.2018.11.008","DOI":"10.1016\/j.ibror.2018.11.008"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"91.\tVamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune\/inflammatory reaction. J Clin Invest 1993;4:1896-1902. https:\/\/doi.org\/10.1172\/JCI116782","DOI":"10.1172\/jci116782"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"92.\tBao A, Fischer D, Wu Y, Hol E, Balesar R, Unmehopa U, Zhou J, Swaab D. A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol Psychiatry 2006;6:567-576. https:\/\/doi.org\/10.1038\/sj.mp.4001800","DOI":"10.1038\/sj.mp.4001800"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"93.\tBibel M, Barde Y. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 2000;14:2919-2937. https:\/\/doi.org\/10.1101\/gad.841400","DOI":"10.1101\/gad.841400"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"94.\tBerton O, McClung CA, DiLeone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006;5762:864-868. https:\/\/doi.org\/10.1126\/science.1120972","DOI":"10.1126\/science.1120972"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"95.\tNumakawa T, Odaka H, Adachi N. Actions of brain-derived neurotrophin factor in the neurogenesis and neuronal function, and its involvement in the pathophysiology of brain diseases. Int J Mol Sci 2018;11:3650. https:\/\/doi.org\/10.3390\/ijms19113650","DOI":"10.3390\/ijms19113650"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"96.\tVerhagen M, van der Meij A, van Deurzen PAM, Janzing JGE, Arias-V\u00e1squez A, Buitelaar JK, Franke B. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010;3:260-271. https:\/\/doi.org\/10.1038\/mp.2008.109","DOI":"10.1038\/mp.2008.109"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"97.\tvon Richthofen S, Lang UE, Hellweg R. Effects of different kinds of acute stress on nerve growth factor content in rat brain. Brain Res 2003;2:207-213. https:\/\/doi.org\/10.1016\/S0006-8993(03)03338-9","DOI":"10.1016\/s0006-8993(03)03338-9"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"98.\tLange I, Meyer H. The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR. J Steroid Biochem Mol Biol 2003;84:159-166. https:\/\/doi.org\/10.1016\/S0960-0760(03)00025-6","DOI":"10.1016\/s0960-0760(03)00025-6"},{"key":"ref98","unstructured":"99.\tCampbell S, MacQueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 2004;6:417-426."},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"100.\tSen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;6:527-532. https:\/\/doi.org\/10.1016\/j.biopsych.2008.05.005","DOI":"10.1016\/j.biopsych.2008.05.005"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"101.\tNomoto H, Baba H, Satomura E, Maeshima H, Takebayashi N, Namekawa Y, Suzuki T, Arai H. Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression. BMC Psychiatry 2015;1:33. https:\/\/doi.org\/10.1186\/s12888-015-0413-1","DOI":"10.1186\/s12888-015-0413-1"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"102.\tEmon MPZ, Das R, Nishuty NL, Shalahuddin Qusar MMA, Bhuiyan MA, Islam MR. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy. BMC Res Notes 2020;1:83. https:\/\/doi.org\/10.1186\/s13104-020-04952-3","DOI":"10.1186\/s13104-020-04952-3"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"103.\tMahmoud R, Wainwright SR, Galea LAM. Sex hormones and adult hippocampal neurogenesis: Regulation, implications, and potential mechanisms. Front Neuroendocrinol 2016;41:129-152. https:\/\/doi.org\/10.1016\/j.yfrne.2016.03.002","DOI":"10.1016\/j.yfrne.2016.03.002"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"104.\tIhara K, Yoshida H, Jones PB, Hashizume M, Suzuki Y, Ishijima H, Kim HK, Suzuki T, Hachisu M. Serum BDNF levels before and after the development of mood disorders: a case-control study in a population cohort. Transl Psychiatr 2016;4:e782-e782. https:\/\/doi.org\/10.1038\/tp.2016.47","DOI":"10.1038\/tp.2016.47"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"105.\tPedrotti Moreira F, Cardoso TC, Mondin TC, Wiener CD, de Mattos Souza LD, Oses JP, Jansen K, da Silva RA. Serum level of nerve growth factor is a potential biomarker of conversion to bipolar disorder in women with major depressive disorder. Psychiatr Clin Neurosci 2019;9:590-593. https:\/\/doi.org\/10.1111\/pcn.12896","DOI":"10.1111\/pcn.12896"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"106.\tRasika S, Alvarez-Buylla A, Nottebohm F. BDNF Mediates the effects of testosterone on the survival of New Neurons in an adult brain. Neuron 1999;1:53-62. https:\/\/doi.org\/10.1016\/S0896-6273(00)80678-9","DOI":"10.1016\/s0896-6273(00)80678-9"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"107.\tEspallergues J, Mamiya T, Vall\u00e9e M, Koseki T, Nabeshima T, Temsamani J, Laruelle C, Maurice T. The antidepressant-like effects of the 3\u03b2-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels. Neuropharmacology 2012;1:492-502. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.09.005","DOI":"10.1016\/j.neuropharm.2011.09.005"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"108.\tSu Q, Cheng Y, Jin K, Cheng J, Lin Y, Lin Z, Wang L, Shao B. Estrogen therapy increases BDNF expression and improves post-stroke depression in ovariectomy-treated rats. Exp Ther Med 2016;3:1843-1848. https:\/\/doi.org\/10.3892\/etm.2016.3531","DOI":"10.3892\/etm.2016.3531"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"109.\tMeltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. The Lancet 2018;10152:1058-1070. https:\/\/doi.org\/10.1016\/S0140-6736(18)31551-4","DOI":"10.1016\/s0140-6736(18)31551-4"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"110.\tPowell JG, Garland S, Preston K, Piszczatoski C. Brexanolone (Zulresso): Finally, an FDA-approved treatment for postpartum depression. Ann Pharmacother 2019;2:157-163. https:\/\/doi.org\/10.1177\/1060028019873320","DOI":"10.1177\/1060028019873320"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"111.\tWirth M. Beyond the HPA axis: progesterone-derived neuroactive steroids in human stress and emotion. Front Endocrinol (Lausanne) 2011;2:19. https:\/\/doi.org\/10.3389\/fendo.2011.00019","DOI":"10.3389\/fendo.2011.00019"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"112.\tAgis-Balboa RC, Guidotti A, Pinna G. 5\u03b1-reductase type I expression is downregulated in the prefrontal cortex\/Brodmann's area 9 (BA9) of depressed patients. Psychopharmacology 2014;17:3569-3580. https:\/\/doi.org\/10.1007\/s00213-014-3567-5","DOI":"10.1007\/s00213-014-3567-5"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"113.\tRasmusson AM, Pinna G, Paliwal P, Weisman D, Gottschalk C, Charney D, Krystal J, Guidotti A. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry 2006;7:704-713. https:\/\/doi.org\/10.1016\/j.biopsych.2006.03.026","DOI":"10.1016\/j.biopsych.2006.03.026"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"114.\tRomeo E, Str\u00f6hle A, Spalletta G, Michele Fd, Hermann B, Holsboer F, Pasini A, Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998;7:910-913. https:\/\/doi.org\/10.1176\/ajp.155.7.910","DOI":"10.1176\/ajp.155.7.910"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"115.\tPinna G, Costa E, Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 2006;3:362-372. https:\/\/doi.org\/10.1007\/s00213-005-0213-2","DOI":"10.1007\/s00213-005-0213-2"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"116.\tUzunova V, Sheline Y, Davis J, Rasmusson A, Uzunov D, Costa E, Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 1998;6:3239-3244. https:\/\/doi.org\/10.1073\/pnas.95.6.3239","DOI":"10.1073\/pnas.95.6.3239"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"117.\tRomeo E, Pompili E, Michele Fd, Pace M, Rupprecht R, Bernardi G, Pasinib A. Effects of fluoxetine, indomethacine and placebo on 3\u03b1, 5\u03b1 tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal. World J Biol Psychiatry 2000;2:101-104. https:\/\/doi.org\/10.3109\/15622970009150572","DOI":"10.3109\/15622970009150572"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"118.\tSch\u00fcle C, Romeo E, Uzunov D, Eser D, Di Michele F, Baghai T, Pasini A, Schwarz M, Kempter H, Rupprecht R. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3\u03b1-hydroxysteroid dehydrogenase activity. Mol Psychiatry 2006;3:261-272. https:\/\/doi.org\/10.1038\/sj.mp.4001782","DOI":"10.1038\/sj.mp.4001782"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"119.\tUgale RR, Hirani K, Morelli M, Chopde CT. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents. Neuropsychopharmacology 2004;9:1597-1609. https:\/\/doi.org\/10.1038\/sj.npp.1300460","DOI":"10.1038\/sj.npp.1300460"},{"key":"ref119","unstructured":"120.\tPrasad A. Efficacy of carbamazepine as an antidepressant in chronic resistant depressives. J Indian Med Assoc 1985;7:235-237."},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"121. \tKobayashi T, Kishimoto A, Inagaki T. Treatment of periodic depression with carbamazepine. Acta Psychiatr Scand 1988;3:364-367. https:\/\/doi.org\/10.1111\/j.1600-0447.1988.tb05137.x","DOI":"10.1111\/j.1600-0447.1988.tb05137.x"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"122.\tKanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 2017;10093:480-489. https:\/\/doi.org\/10.1016\/S0140-6736(17)31264-3","DOI":"10.1016\/s0140-6736(17)31264-3"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"123.\tKanes SJ, Colquhoun H, Doherty J, Raines S, Hoffmann E, Rubinow DR, Meltzer\u2010Brody S. Open\u2010label, proof\u2010of\u2010concept study of brexanolone in the treatment of severe postpartum depression. Hum Psychopharmacol Clin Exp 2017;2:e2576. https:\/\/doi.org\/10.1002\/hup.2576","DOI":"10.1002\/hup.2576"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"124.\tMeltzer-Brody S, Kanes SJ. Allopregnanolone in postpartum depression: Role in pathophysiology and treatment. Neurobiol Stres 2020;12:100212. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100212","DOI":"10.1016\/j.ynstr.2020.100212"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"125.\tChen CV, Jordan CL, Breedlove SM. Testosterone works through androgen receptors to modulate neuronal response to anxiogenic stimuli. Neurosci Lett 2021;753:135852. https:\/\/doi.org\/10.1016\/j.neulet.2021.135852","DOI":"10.1016\/j.neulet.2021.135852"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"126.\tSternbach H. Age-associated testosterone decline in men: clinical issues for psychiatry. Am J Psychiatry 1998;10:1310-1318. https:\/\/doi.org\/10.1176\/ajp.155.10.1310","DOI":"10.1176\/ajp.155.10.1310"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"127.\tKhera M, Bhattacharya R, Blick Md G, Kushner H, Nguyen D, Miner M. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male 2011;15:14-21. https:\/\/doi.org\/10.3109\/13685538.2011.606513","DOI":"10.3109\/13685538.2011.606513"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"128.\tZarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 2009;4:289-305. https:\/\/doi.org\/10.1097\/01.pra.0000358315.88931.fc","DOI":"10.1097\/01.pra.0000358315.88931.fc"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"129.\tAmiaz R, Seidman SN. Testosterone and depression in men. Curr Opin Endocrinol Diabetes Obes 2008;3:278-283. https:\/\/doi.org\/10.1097\/MED.0b013e3282fc27eb","DOI":"10.1097\/MED.0b013e3282fc27eb"},{"key":"ref129","unstructured":"130.\tShores MM: Men's Health and Psychiatry. In: Design and Implementation of the Modern Men's Health Center. ALUKAL JP, LAMM S, WALSH TJ (eds), Springer Nature Switzerland, 2021, pp 231-248."},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"131.\tVartolomei MD, Kimura S, Vartolomei L, Shariat SF. Systematic review of the impact of testosterone replacement therapy on depression in patients with late-onset testosterone deficiency. Eur Urol Focus 2020;1:170-177. https:\/\/doi.org\/10.1016\/j.euf.2018.07.006","DOI":"10.1016\/j.euf.2018.07.006"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T15:22:33Z","timestamp":1674487353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2022\/71_S187.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":131,"journal-issue":{"issue":"Suppl. 2","published-online":{"date-parts":[[2022,12,30]]}},"URL":"https:\/\/doi.org\/10.33549\/physiolres.935001","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}